Document Detail

[Descemetectomy as therapy option for visually disturbing roll in Descemet's membrane].
MedLine Citation:
PMID:  23392855     Owner:  NLM     Status:  MEDLINE    
PURPOSE: The aim was to demonstrate the feasibility of targeted removal of a central visually disturbing roll in Descemet's membrane after complicated cataract surgery.
CASE REPORT: a 76-year-old patient complained of halos and reduced visual acuity after external cataract surgery. At slit-lamp examination a central roll in Descemet's membrane was found (2 × 2 mm).
RESULTS: A targeted central descemetectomy was performed by circular descemetorhexis around the defect. Early postoperative visual acuity improved and halos disappeared. At 2 months postoperatively best corrected visual acuity (BCVA) was 1.0 and the endothelial cell count was not significantly changed.
CONCLUSIONS: Central targeted descemetorhexis is a safe therapeutic option for visually disturbing defects of Descemet's membrane.
C Cursiefen; B Bachmann
Publication Detail:
Type:  Case Reports; English Abstract; Journal Article    
Journal Detail:
Title:  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft     Volume:  110     ISSN:  1433-0423     ISO Abbreviation:  Ophthalmologe     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-08-30     Completed Date:  2014-04-08     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  9206148     Medline TA:  Ophthalmologe     Country:  Germany    
Other Details:
Languages:  ger     Pagination:  872-5     Citation Subset:  IM    
Vernacular Title:
Descemetektomie als Therapieoption bei zentraler visusbeeinträchtigender Descemet-Rolle.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cataract Extraction / adverse effects*
Descemet Membrane / injuries*,  surgery*
Descemet Stripping Endothelial Keratoplasty / methods*
Feasibility Studies
Treatment Outcome
Vision Disorders / diagnosis,  etiology*,  prevention & control*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Stage IV Melanoma: Completely Resectable Patients are Scarce.
Next Document:  Flos Lonicerae Extracts and Chlorogenic Acid Protect Human Umbilical Vein Endothelial Cells from the...